Phase III Randomized Study of RFS 2000 (9-Nitro-Camptothecin 9-NC) [rubitecan] Versus Most Appropriate Therapy in Refractory Pancreatic Cancer Patients.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 23 Jul 2008
At a glance
- Drugs Fluorouracil; Gemcitabine; Mitomycin; Rubitecan
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- 23 Jul 2008 Astex Pharmaceuticals added as trial associate as reported by ClinicalTrials.gov.
- 23 Jul 2008 Trial Centre updated as reported by ClinicalTrials.gov.
- 04 Oct 2005 New trial record.